Neogen Corporation (NEOG)

NasdaqGS · Medical Devices

11.82
-0.44 (-3.59%)
Updated Nov 2, 4:29 AM ET
AI Rating
Hold
Overall Score
61
Trend
57
Momentum
63
Risk
64

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 20, 2025 260 sessions Oct 30, 2026

AI Analysis

Neogen Corporation is trading at $11.82, down 3.59% on the session. The 50 day average sits at $12.19 and the 200 day at $10.35, which puts the stock in a uptrend. RSI is at 50.9, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $11.59 with resistance near $12.26, so that band frames the current range. Average daily movement is roughly $0.57, or about 4.8% of the share price, which is what any stop placement has to allow for. The overall health score of 51 out of 100 combines a trend score of 64, momentum of 33 and a risk score of 54.

Technical indicators

RSI (14)
45.2
neutral
MACD
-0.054
bullish crossover
SMA 20
12.02
SMA 50
12.23
SMA 200
10.42
uptrend
ATR (14)
0.54
avg daily range
Support
11.59
Resistance
12.18
Volume vs 20d
0.50x
below average
Volatility
50.8%
annualised
1 month
-3.43%
3 months
-0.67%

About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.